End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation.
Lobato
L
L
Department of Nephrology, and Liver Transplantation Program, Hospital Geral de Santo António, Largo Professor Abel Salazar, 4050, Porto, Portugal. llobato@nctcabo.pt
Ventura
A
A
Beirão
I
I
Miranda
H P
HP
Seca
R
R
Henriques
A C
AC
Teixeira
M
M
Sarmento
A M
AM
Pereira
M C
MC
D019943:Amino Acid Substitution; D028227:Amyloid Neuropathies, Familial / Q000235:genetics* / Q000601:surgery*; D019072:Antibiotic Prophylaxis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D025063:Chromosome Disorders / Q000235:genetics / Q000601:surgery; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000601:surgery*; D016030:Kidney Transplantation; D016031:Liver Transplantation; D020125:Mutation, Missense; D018579:Patient Selection; D011183:Postoperative Complications / Q000382:microbiology / Q000517:prevention & control / Q000821:virology; D011184:Postoperative Period; D011228:Prealbumin / Q000235:genetics*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011228:Prealbumin; D016572:Cyclosporine; D001379:Azathioprine